Effect of pentoxifylline in myocardial infartio
Phase 2
- Conditions
- myocardial infarction.Diseases of the circulatory ystem
- Registration Number
- IRCT2015102624722N1
- Lead Sponsor
- Cardiovascular Research Center, Tabriz University Of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
inclusion criteria:
patients with over 18 year; patients with acute anterior myocardial infarction; patients undergoing thrombolytic therapy exclusion criteria: history of coronary artery by pass graft; history of myocardial infarction; history of renal failure; sensitivity to aspirin,clopidogrel or pentoxifylline; cardiogenic shock
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Check of cardiac enzymes(cpk ,CK-MB). Timepoint: check at base then every 8 hour until 48 hour. Method of measurement: Enzymes chec.
- Secondary Outcome Measures
Name Time Method The st-resolution rate at 90 minute after given thrombolytic. Timepoint: 90 minute after given thrombolytic. Method of measurement: percent of st decline.